For the metastasis stage, RHBDF2 overexpression was related to unfavorable OS, PFS and DSS in HCC patients with M0, but related to good PFS and DSS in HCC patients with MX (Fig. 4A,C,D). The gene discussed is RHBDF2; the disease is hepatocellular carcinoma.